Biomerica Announces Notice of Allowance for New U.S. Patent Application Covering Diagnostic Guided Therapy for Irritable Bowel Syndrome (IBS) and Provides Progress Update on COVID-19 antibody tests
IRVINE, Calif., Aug. 12, 2020 (GLOBE NEWSWIRE) — Biomerica Inc. (NASDAQ: BMRA) announced today that the United States Patent and […]